We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
223 hedge funds and large institutions have $176M invested in Sorrento Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 74 increasing their positions, 50 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
48% more call options, than puts
Call options by funds: $3.58M | Put options by funds: $2.42M
48% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 50
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 233 → 223 (-10)
17% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 41
32% less capital invested
Capital invested by funds: $260M → $176M (-$84.2M)
Holders
223
Holders Change
-10
Holders Change %
-4.29%
% of All Funds
3.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
34
Increased
74
Reduced
50
Closed
41
Calls
$3.58M
Puts
$2.42M
Net Calls
+$1.16M
Net Calls Change
-$4.96M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$13.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.31M |
| 3 |
BlackRock
New York
|
+$6.96M |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$6.92M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.85M |
